Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Neurol Clin. 2015 Feb 28;33(2):491–500. doi: 10.1016/j.ncl.2015.01.002

Fig. 3.

Fig. 3

Estimated proportion of strokes attributable to PFO for patients with CS and estimated risk of stroke/TIA recurrence within 2 years as a function of RoPE score (x-axis). ◆ and % in boxes represent stratum-specific PFO prevalence.